Zelira Therapeutics (ASX:ZLD) — Material Events
ASX:ZLD · 7 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Zelira Secures US$33M to Propel HOPE® 1 Autism Drug Through FDA TrialsHigh
Zelira raises US$33M with ThirdGate Capital for HOPE® 1 autism drug FDA trials
16 Jan 2026
·Capital Raising
·85
Zelira Therapeutics Secures US$33M to Accelerate HOPE 1 FDA TrialsMedium
Zelira Therapeutics raises US$33M for HOPE 1 FDA trials, receives $1.07M R&D refund
29 Jan 2026
·Quarterly Activities Report and Appendix 4C
·85
Zelira’s ZLT-L-007 Outperforms Lyrica, Strengthens Funding for HOPE® 1 TrialsMedium
Zelira advances diabetic neuropathy drug study, converts $3.25M notes to equity, secures $650k loan
30 July 2025
·Quarterly Activities Report
·80
Zelira Therapeutics Narrows FY25 Loss, Advances HOPE® FDA Trials and Patent PortfolioMedium
Zelira Therapeutics narrows FY25 loss to AUD 3.85M, advances HOPE® clinical trials and patent portfolio
29 Aug 2025
·Appendix 4E Preliminary Final Report
·75
Zelira Advances HOPE 1 FDA Trials, Secures $650k R&D Loan Amid Cash BurnMedium
Zelira advances HOPE 1 FDA trials, secures $650k R&D loan, reports $711k cash burn in Q1 FY2026
27 Oct 2025
·Quarterly Activities Report and Appendix 4C
·75
Zelira Therapeutics Secures $650K Non-Dilutive Loan to Boost Clinical TrialsMedium
Zelira Therapeutics secures $650K R&D loan facility to fund clinical trial and working capital
24 July 2025
·Loan Facility Announcement
·70
Zelira Therapeutics Secures $1.07M R&D Refund to Boost Clinical PipelineMedium
Zelira Therapeutics receives $1.07M R&D tax refund to fund clinical and product development
25 Nov 2025
·ASX Announcement
·70
No articles in this tier for the last 12 months.
Market Mentions
2
- appeared in market wrap coverage
These are market wrap articles where Zelira Therapeutics (ASX:ZLD) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Market Wrap - Week 3 (12 Jan -> 16 Jan) 2026
18 Jan 2026